Your browser doesn't support javascript.
loading
RAS-pathway mutations are common in patients with ruxolitinib refractory/intolerant myelofibrosis: molecular analysis of the PAC203 cohort.
O'Sullivan, J M; Taylor, J; Gerds, A; Buckley, S; Harrison, C N; Oh, S; List, A F; Howard, K; Dreau, H; Hamblin, A; Mead, A J.
Afiliação
  • O'Sullivan JM; NIHR Biomedical Research Centre and MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK. jennifer.osullivan@rdm.ox.ac.uk.
  • Taylor J; Department of Clinical Haematology, Guy's and St Thomas NHS Foundation Trust, London, UK. jennifer.osullivan@rdm.ox.ac.uk.
  • Gerds A; Astex Pharmaceuticals, Inc., Pleasanton, CA, USA.
  • Buckley S; Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
  • Harrison CN; CTI BioPharma Corp., Seattle, WA, USA.
  • Oh S; Department of Clinical Haematology, Guy's and St Thomas NHS Foundation Trust, London, UK.
  • List AF; Washington University School of Medicine, Saint Louis, MO, USA.
  • Howard K; Precision BioSciences, Inc., Durham, NC, USA.
  • Dreau H; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Hamblin A; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Mead AJ; NIHR Biomedical Research Centre and MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Leukemia ; 37(12): 2497-2501, 2023 12.
Article em En | MEDLINE | ID: mdl-37864122
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mielofibrose Primária Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mielofibrose Primária Idioma: En Ano de publicação: 2023 Tipo de documento: Article